Key points
- CDC's Advanced Molecular Detection (AMD) program is helping build and integrate the use of genomic sequencing technologies into public health nationwide.
- The cumulative local investment to California from FY2021-2023 is $64,924,372.
- California receives customized AMD support as part of the Western region.
- The University of California (Los Angeles, Santa Cruz, San Diego, and San Francisco), Scripps Research Institute, and Laboratory Corporation of America have received research awards to advance pathogen genomics for public health.
Total investment: $64,924,372*
- State and Local Investment: $49,381,131
- Research Awards: $15,543,241
* Investments listed above do not include Los Angeles County, which receives direct financial support through the ELC Cooperative Agreement.
Funding to public health departments includes support from the American Rescue Plan Act of 2021, AMD annual appropriations in FY2021-2023, and NCEZID annual appropriations. The investment above also includes supplemental funding for facility construction and renovation needs.
Implementing AMD technology
The AMD program builds and integrates laboratory, bioinformatics, and epidemiology technologies across CDC and nationwide. Since 2014, AMD has received support from Congress—now a $40 million per year appropriation—to implement these technologies in public health programs. Through investments in AMD technologies, CDC is improving both public health outcomes and preparedness in dozens of areas including foodborne disease, influenza, antibiotic resistance, hepatitis, pneumonia, and meningitis.
With funding from the American Rescue Plan Act of 2021, the AMD program developed a multi-year plan to expand its support to state, local, and territorial public health laboratories with more staff and resources to collect specimens for COVID-19 testing, sequence them to identify and track SARS-CoV-2 variants, and share data, now and future years.
Workforce development
California is part of the Western region. In 2018, the AMD program established seven workforce development regions across the country. Each region has an AMD training lead and a bioinformatics lead. This provides a network of customized AMD support which helps develop skills and provides training assistance to public health labs across the country.
Through the Western region's training resources, California receives lab support on data analysis and how to interface with IT departments. They also receive both pathogen-specific training and cross-cutting instruction to help staff develop the critical skills necessary to extract, analyze, and interpret sequencing data.
University and research partners in California
These awards are intended to fill knowledge gaps and promote innovation in the U.S. response to the COVID-19 pandemic. Funding awards are determined through a competitive selection process based on scientific needs and available funds.
2023 Project: University of California, Los Angeles (UCLA)
2023 Project: University of California, San Diego (UCSD)
2022 Project: University of California, San Francisco (UCSF)
2022 Project: Scripps Research Institute
2021 Project: University of California, Santa Cruz (UCSC)
2021 Project: University of California, San Francisco (UCSF)
2020 Project: Scripps Research Institute
Awards to university and research partners were funded through appropriations supporting the COVID-19 response.